← Leaderboards
Frank Zemlan
P2d, Inc.
$4,956,009
Attributed
$6,251,086
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2006–15$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$6,251,086 · 13
By mechanism
R44$3,949,224 · 3
R43$2,301,862 · 10
Top collaborators
- Stephen C Benoit3 shared
- Maisam Abu-El-Haija1 shared
- Jorge A. Bezerra1 shared
- Marni E Harris-White1 shared
Others in their field
Top investigators on “Small Business Innovation Research Grant”
- David Heimbrook · Leidos Biomedical Research, Inc.$122,677,088
- Praduman Jain · Vignet, Inc.$106,968,877
- Stephen Lev Hoffman · Sanaria, Inc.$37,771,680
- Eric Baer · Case Western Reserve University$37,136,000
- John B Buse · University Of North Carolina Chapel Hill$23,865,764
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
Research focus
Small Business Innovation Research GrantPharmaceutical PreparationsDoseAcuteMutationPreclinical StudyAnalogPre-ClinicalRattusAffectAdverse EffectsHepatocyteLibrariesChildScheduleBenztropineChronicAffinityMaleSafetyDrug Of AbuseLeadDopamineTransport Inhibitor
Grant awards (17)
LIVERCHIP - A diagnostic tool for genetic liver diseases$560,619
R44 · FY2015 · DK · contact PI
PancreasCHIP - A diagnostic tool for Inheritable Pancreatic Disease$266,046
R43 · FY2015 · DK · contact PI
LIVERCHIP - A diagnostic tool for genetic liver diseases$617,897
R44 · FY2014 · DK · contact PI
Novel Alzheimer's Disease Drug Treatment$224,905
R43 · FY2014 · AG · contact PI
Phase 2 Selective DAT inhibitor for treatment of Obesity.$740,782
R44 · FY2012 · DK · contact PI
ADHD Therapeutic: PD2005 DA Transport Inhibitor$599,030
R44 · FY2012 · MH · contact PI
JAUNDICE NEXT: A diagnostic tool for cholestatic liver disease.$344,780
R43 · FY2012 · DK
ADHD Therapeutic: PD2005 DA Transport Inhibitor$183,605
R44 · FY2012 · MH · contact PI
Phase 2 Selective DAT inhibitor for treatment of Obesity.$766,488
R44 · FY2011 · DK · contact PI
ADHD Therapeutic: PD2005 DA Transport Inhibitor$480,803
R44 · FY2011 · MH · contact PI
Y2 and Y4 Agonists in Obesity$247,153
R43 · FY2010 · DK · contact PI
Selective DAT Inhbitor for the Treatment of Obesity$212,981
R43 · FY2008 · DK · contact PI
COCAINE THERAPEUTIC: PD2007$242,814
R43 · FY2007 · DA · contact PI
Efficacy of the Melatonin Agonist in the Treatment of Depression$233,954
R43 · FY2007 · MH · contact PI
Selective DAT Inhibitor for Treatment of ADHD$228,706
R43 · FY2007 · MH · contact PI
Ethanol Interactions of the Melatonin Agonist PD6735$24,678
R43 · FY2007 · MH · contact PI
Melatonin Analog PD6735 and Anxiety$275,845
R43 · FY2006 · MH · contact PI